The substitution of Phentolamine with an equal amount of Chlopromazine as an alpha-blocker in vasoactive cocktails used for intracavernous injection therapy for the treatment of erectile dysfunction

Uebel, R.; Schmidt, Abraham C

doi:10.1080/20786204.2007.10873496

Cited by 1 publication

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[9] Over 15 years later, the substitution of phentolamine with chlorpromazine as an alpha-blocker in vasoactive cocktails for intracavernous injection therapy to treat ED was investigated. [15] Results indicated that 96% (n=364) of patients were satisfied with the new treatment, with no significant side-effects reported.…”

Section: Description Of the Studiesmentioning

confidence: 85%

“…[6][7][8][9][10][11][12][13] Nine were published in SA journals, eight in general medical journals (the South African Medical Journal (SAMJ) (n=6) and South African Family Practice (SAFP) (n=2)) and one in a specialist medical journal (the South African Journal of Psychiatry (SAJP)). [14][15][16][17][18][19][20][21][22] The first article was published in the SAMJ in 1976, while the most recent publication appeared in SAFP in 2013. These articles are summarised in Table 1.…”

Section: Resultsmentioning

confidence: 99%

“…Despite the high prevalence of ejaculatory and erectile dysfunctions reported in the international literature, [2] only five SA articles [9,[14][15][16][17] have addressed the topic of male sexual dysfunction since 1970, with an exclusive focus on ED. Lack of sexual interest and inability to reach orgasm are the most commonly reported complaints for women, [2] yet only four SA articles [7,8,18,19] have been published on the topic of female sexual dysfunction.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Sexual dysfunction: A systematic review of South African research

Campbell

Stein²

2014

S Afr Med J

View full text Add to dashboard Cite

Results of this survey indicated that psychiatrists considered the sexual dysfunction (F52) disorders of the ICD-10 as having low ease of use and poor goodness of fit, suggesting the need for considerable revision in the ICD-11 to improve clinical utility.Background. The World Health Organization is in the process of revising the International Classification of Diseases and Related Health Problems (ICD). Sexual dysfunction disorders (F52) have been identified as having poor clinical utility. South Africa (SA) has been selected as one of five low-and middle-income countries in which studies will be developed to assess the clinical utility of the proposed ICD-11 revisions for sexual dysfunction disorders. Objective. To identify scientific research generated in SA on sexual dysfunction disorders to guide these studies. Methods. A systematic review of SA research on sexual dysfunction disorders published in peer-reviewed journals. Results. Despite the high prevalence of ejaculatory and erectile dysfunctions, only five SA articles have addressed male sexual dysfunction since 1970. Lack of sexual interest and inability to reach orgasm are the most commonly reported complaints for women, yet only four SA articles have been published on the topic of female sexual dysfunction. Diabetes mellitus, cardiovascular disease, genitourinary disease and psychiatric or psychological disorders are common comorbid conditions associated with sexual dysfunction in both sexes, but only nine articles address sexual dysfunction as the main topic with respect to comorbid conditions. Conclusion. Despite growing awareness of the importance of sexual health, SA-based scientific research on sexual dysfunction is limited. Further work is needed to inform recommendations for ICD-11 revisions drawn from the SA context.

show abstract

Section: Description Of the Studiesmentioning

confidence: 85%